Trust Point’s Medpace MEDP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$681K Sell
1,091
-75
-6% -$43.9K 0.05% 197
2026
Q2
$618K Sell
1,166
-604
-34% -$279K 0.05% 188
2026
Q1
$850K Sell
1,770
-27
-2% -$13.8K 0.07% 146
2025
Q4
$1.01M Sell
1,797
-414
-19% -$235K 0.08% 118
2025
Q3
$1.14M Buy
2,211
+270
+14% +$118K 0.09% 113
2025
Q2
$609K Sell
1,941
-1,127
-37% -$338K 0.06% 155
2025
Q1
$935K Sell
3,068
-1,760
-36% -$592K 0.09% 122
2024
Q4
$1.6M Sell
4,828
-1,316
-21% -$446K 0.11% 92
2024
Q3
$2.05M Sell
6,144
-378
-6% -$144K 0.15% 69
2024
Q2
$2.69M Buy
6,522
+121
+2% +$47.9K 0.22% 45
2024
Q1
$2.59M Buy
6,401
+1,507
+31% +$530K 0.2% 52
2023
Q4
$1.5M Buy
+4,894
New +$1.32M 0.12% 87

Other funds holding MEDP

Trust Point's MEDP Position: Q3 2026 in Review

Trust Point reduced its Medpace (MEDP) stake by 6.4% in Q3 2026, selling an estimated $43.9K and leaving 1,091 shares worth $681K. The position accounts for 0.05% of the portfolio, ranked #197.

Trust Point first reported a position in MEDP in Q4 2023 and has held it in 12 quarters since. The position peaked at $2.69M in Q2 2024. 619 funds tracked by Wall St. Rank hold MEDP as of Q3 2026.

  • Trust Point held 1,091 shares of Medpace worth $681K as of Q3 2026.
  • Trust Point sold 75 Medpace shares in Q3 2026, an estimated $43.9K.
  • Medpace made up 0.05% of Trust Point's portfolio in Q3 2026, its #197 holding.
  • Trust Point first reported a position in Medpace in Q4 2023 and has held it in 12 quarters since.
  • Trust Point's Medpace position peaked at $2.69M in Q2 2024.
  • 619 funds tracked by Wall St. Rank held Medpace as of Q3 2026.

Based on Trust Point's 13F filing for Q3 2026, filed 27 Oct 2026.